Skip to main content
Fig. 5 | Cardiovascular Diabetology

Fig. 5

From: Evidence that tirzepatide protects against diabetes-related cardiac damages

Fig. 5

Protective Effects of TZT on cell proliferation, viability, and toxicity A AC16 cell proliferation analysis performed after cell staining with Ki-67 marker and the histogram represents median of fluorescence (FITC). B Cell viability was assessed using a CCK-8 assay after 7 days of exposure to normal glucose (NG), high glucose (HG), or HG with 100 nM TZT. (C) Cell toxicity assay performed with Lactate dehydrogenase (LDH) activity assay. Data are presented as mean ± SEM of three independent experiments. *p < vs NG; ** p < vs HG

Back to article page